Digirad Corp (DRAD):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Digirad Corp (DRAD) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6638
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Digirad Corp (Digirad) is a medical device company that provides mobile and on-site imaging solutions. The company provides camera products such as ergo, cardius x-ACT, cardius 2 XPO, corcam, quantumcam, cardius 3 XPO, and others. It provides diagnostic services such as nuclear cardiology, ultrasound, neuropathy testing, telerhythmics, technology refresh, healthcare system partnerships, staffing services, and others. Digirad provides healthcare spectrum such as mobile diagnostic imaging, solid-state nuclear imaging, cardiac monitoring, women’s health services, and others. The company products serve cardiologists, internal medicine physicians, and family practice doctors, hospitals, multi-practice physician groups and imaging centers. It offers camera maintenance services to physician offices, hospitals, mobile service providers, imaging centers, and others. Digirad is headquartered in Suwanee, Georgia, the US.

Digirad Corp (DRAD) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Digirad Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Digirad Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Digirad Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Digirad Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Digirad Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Digirad Corp, Medical Equipment, Deal Details 10
Private Equity 10
Platinum Equity Completes Acquisition Of DMS Health Technologies 10
Partnerships 11
Digirad Enters into Agreement with Perma-Fix Medical 11
Digirad Enters Into Distribution Agreement With Dilon Diagnostics 12
Asset Transactions 13
Philips North America Acquires Medical Device Sales and Service Business Unit from Digirad for USD8 Million 13
Novadaq Technologies Acquires Surgical Imaging Technology Assets From Digirad For USD3 Million 14
Acquisition 16
Digirad Acquires DMS Health Technologies from Platinum Equity for USD36 Million 16
Digirad Acquires 5.4% Stake in Perma-Fix Medical for USD1 Million 17
Digirad Acquires MD Office Solutions for USD3 Million 18
Digirad Acquires Telerhythmics For USD4 Million 19
Digirad Corp – Key Competitors 20
Digirad Corp – Key Employees 21
Digirad Corp – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Aug 02, 2018: Digirad reports financial results for the second quarter and six months ended June 30, 2018 23
May 01, 2018: Digirad Reports Financial Results for the First Quarter Ended March 31, 2018 24
Feb 23, 2018: Digirad Reports Financial Results for the Fourth Quarter Ended December 31, 2017 25
Nov 03, 2017: Digirad Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2017 26
Aug 04, 2017: Digirad Reports Financial Results for the Second Quarter and Six Months Ended June 30, 2017 27
Apr 28, 2017: Digirad Reports Financial Results for the First Quarter Ended March 31, 2017 28
Feb 24, 2017: Digirad Reports Financial Results for the Fourth Quarter and Twelve Months ended December 31, 2016 29
Corporate Communications 30
Mar 30, 2018: Digirad Announces Personnel Changes 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Digirad Corp, Medical Equipment, Key Facts, 2017 2
Digirad Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Digirad Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Digirad Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Digirad Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Digirad Corp, Deals By Market, 2012 to YTD 2018 8
Digirad Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Platinum Equity Completes Acquisition Of DMS Health Technologies 10
Digirad Enters into Agreement with Perma-Fix Medical 11
Digirad Enters Into Distribution Agreement With Dilon Diagnostics 12
Philips North America Acquires Medical Device Sales and Service Business Unit from Digirad for USD8 Million 13
Novadaq Technologies Acquires Surgical Imaging Technology Assets From Digirad For USD3 Million 14
Digirad Acquires DMS Health Technologies from Platinum Equity for USD36 Million 16
Digirad Acquires 5.4% Stake in Perma-Fix Medical for USD1 Million 17
Digirad Acquires MD Office Solutions for USD3 Million 18
Digirad Acquires Telerhythmics For USD4 Million 19
Digirad Corp, Key Competitors 20
Digirad Corp, Key Employees 21
Digirad Corp, Other Locations 22
Digirad Corp, Subsidiaries 22

List of Figures
Digirad Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Digirad Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Digirad Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Digirad Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Digirad Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Digirad Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Digirad Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Digirad Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Digirad Corp (DRAD):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Welltower Inc:企業のM&A・事業提携・投資動向
    Welltower Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Welltower Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • SMRT Corporation Ltd.:戦略・SWOT・企業財務分析
    SMRT Corporation Ltd. - Strategy, SWOT and Corporate Finance Report Summary SMRT Corporation Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Protalix BioTherapeutics Inc (PLX):企業の財務・戦略的SWOT分析
    Protalix BioTherapeutics Inc (PLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Gulf Power Co:電力:M&Aディール及び事業提携情報
    Summary Gulf Power Co (Gulf Power), a subsidiary of Southern Company, is an integrated energy utility. It generates, procures, transmits, and distributes electricity. The company produces electricity using coal and gas sources. Through agreements with industrial, commercial, and qualifying facilitie …
  • Pharmaxis Ltd (PXS):企業の財務・戦略的SWOT分析
    Summary Pharmaxis Ltd (Pharmaxis) is a pharmaceutical research company that develops and commercialize healthcare products. The company provides products such as aridol which identify twitchy and assist in diagnosing and managing asthma, and bronchitol which restores normal lung hydration, improves …
  • Clarins SA:企業の戦略・SWOT・財務情報
    Clarins SA - Strategy, SWOT and Corporate Finance Report Summary Clarins SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • CarMax, Inc.:企業の戦略・SWOT・財務情報
    CarMax, Inc. - Strategy, SWOT and Corporate Finance Report Summary CarMax, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Syros Pharmaceuticals Inc (SYRS):企業の財務・戦略的SWOT分析
    Summary Syros Pharmaceuticals Inc (Syros) is a biopharmaceutical company that develops medicines for the treatment of cancer, immune-mediated diseases, and other diseases. The company’s pipeline products under clinical trials include SY-1425, an oral, potent and selective RARa agonist that is used t …
  • Vornado Realty Trust:企業の戦略・SWOT・財務分析
    Vornado Realty Trust - Strategy, SWOT and Corporate Finance Report Summary Vornado Realty Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Lannett Company Inc (LCI):企業の財務・戦略的SWOT分析
    Lannett Company Inc (LCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • MEDITE Cancer Diagnostics Inc (MDIT):企業の財務・戦略的SWOT分析
    MEDITE Cancer Diagnostics Inc (MDIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • The Aerospace Corporation:企業の戦略的SWOT分析
    The Aerospace Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Applied Medical Resources Corporation:企業の戦略的SWOT分析
    Applied Medical Resources Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Globus Medical, Inc. (GMED)-医療機器分野:企業M&A・提携分析
    Summary Globus Medical, Inc. (Globus) is a medical device company which manufactures and markets musculoskeletal implants with focus on the treatment of spine disorders. The company’s product portfolio includes biomaterial products, cervical, deformity, intervertebral fusion, minimally invasive, mot …
  • Opiant Pharmaceuticals Inc (OPNT):企業の財務・戦略的SWOT分析
    Opiant Pharmaceuticals Inc (OPNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Softship AG:企業の戦略的SWOT分析
    Softship AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Juntendo University-製薬・医療分野:企業M&A・提携分析
    Summary Juntendo University (Juntendo) is a healthcare service provider that offers medical education and research services. The institute offers medical education, practices and healthcare services which include consultation, nursing, emergency room, and others. Its services comprise radiology, spo …
  • Parkson Retail Group Limited:戦略・SWOT・企業財務分析
    Parkson Retail Group Limited - Strategy, SWOT and Corporate Finance Report Summary Parkson Retail Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Richelieu Hardware Ltd:企業の戦略・SWOT・財務情報
    Richelieu Hardware Ltd - Strategy, SWOT and Corporate Finance Report Summary Richelieu Hardware Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • ContraVir Pharmaceuticals Inc (CTRV):製薬・医療:M&Aディール及び事業提携情報
    Summary ContraVir Pharmaceuticals Inc (ContraVir) is a biopharmaceutical company that offers development and commercialization of targeted antiviral therapies. The company provides pipeline product such as TXL, potent prodrug of antiviral tenofovir and CRV431 cyclophilin inhibitor that increases its …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆